Abstract
Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have